GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,331,571 | -8.4% | 268,511 | +9.9% | 0.08% | -2.5% |
| Q2 2023 | $14,546,931 | +11.9% | 244,322 | +6.5% | 0.08% | +6.6% |
| Q1 2023 | $12,997,000 | -73.0% | 229,468 | -65.1% | 0.08% | -74.2% |
| Q4 2022 | $48,062,000 | +22.2% | 656,949 | -0.5% | 0.30% | +14.8% |
| Q3 2022 | $39,321,000 | -25.1% | 660,088 | -29.4% | 0.26% | -21.9% |
| Q2 2022 | $52,519,000 | +189.2% | 935,512 | +280.1% | 0.33% | +253.8% |
| Q1 2022 | $18,160,000 | -1.9% | 246,145 | -3.6% | 0.09% | +14.8% |
| Q4 2021 | $18,520,000 | -8.3% | 255,425 | -3.1% | 0.08% | -11.0% |
| Q3 2021 | $20,206,000 | -21.9% | 263,721 | -21.0% | 0.09% | -18.0% |
| Q2 2021 | $25,874,000 | +26.3% | 333,731 | +0.8% | 0.11% | +22.0% |
| Q1 2021 | $20,486,000 | +24.7% | 331,223 | +31.5% | 0.09% | -2.2% |
| Q4 2020 | $16,426,000 | +4.0% | 251,864 | -22.0% | 0.09% | +14.8% |
| Q3 2020 | $15,788,000 | +3.7% | 322,881 | +0.5% | 0.08% | -6.9% |
| Q2 2020 | $15,232,000 | +29.6% | 321,357 | +16.3% | 0.09% | +19.2% |
| Q1 2020 | $11,752,000 | +14.7% | 276,325 | +58.7% | 0.07% | +49.0% |
| Q4 2019 | $10,248,000 | +17.8% | 174,064 | +2.3% | 0.05% | +8.9% |
| Q3 2019 | $8,697,000 | +22.7% | 170,147 | +1.5% | 0.04% | +25.0% |
| Q2 2019 | $7,089,000 | +9.1% | 167,598 | +27.5% | 0.04% | +2.9% |
| Q1 2019 | $6,496,000 | +15.0% | 131,487 | +0.7% | 0.04% | -2.8% |
| Q4 2018 | $5,648,000 | -23.3% | 130,511 | +0.6% | 0.04% | 0.0% |
| Q3 2018 | $7,363,000 | +11.9% | 129,734 | -0.5% | 0.04% | +2.9% |
| Q2 2018 | $6,580,000 | +7.4% | 130,404 | +6.1% | 0.04% | +6.1% |
| Q1 2018 | $6,124,000 | +29.9% | 122,937 | +7.2% | 0.03% | +26.9% |
| Q4 2017 | $4,716,000 | -0.5% | 114,636 | -26.5% | 0.03% | -3.7% |
| Q3 2017 | $4,738,000 | -4.3% | 155,988 | +4.4% | 0.03% | -10.0% |
| Q2 2017 | $4,953,000 | +13.7% | 149,438 | +1.6% | 0.03% | +11.1% |
| Q1 2017 | $4,355,000 | +26.7% | 147,030 | +6.1% | 0.03% | +17.4% |
| Q4 2016 | $3,437,000 | -7.9% | 138,554 | -16.2% | 0.02% | -8.0% |
| Q3 2016 | $3,730,000 | +7.8% | 165,298 | +13.8% | 0.02% | +4.2% |
| Q2 2016 | $3,461,000 | +3.9% | 145,243 | +3.6% | 0.02% | +4.3% |
| Q1 2016 | $3,330,000 | -19.3% | 140,212 | -5.5% | 0.02% | -17.9% |
| Q4 2015 | $4,127,000 | -47.1% | 148,377 | -60.7% | 0.03% | +3.7% |
| Q3 2015 | $7,808,000 | +74.7% | 378,006 | +117.1% | 0.03% | +8.0% |
| Q2 2015 | $4,469,000 | +45.6% | 174,123 | +43.1% | 0.02% | +38.9% |
| Q1 2015 | $3,070,000 | -14.8% | 121,669 | -19.7% | 0.02% | -14.3% |
| Q4 2014 | $3,602,000 | -52.0% | 151,568 | -60.3% | 0.02% | 0.0% |
| Q3 2014 | $7,510,000 | -31.8% | 381,882 | -17.0% | 0.02% | -65.0% |
| Q2 2014 | $11,010,000 | -19.7% | 460,303 | -10.7% | 0.06% | -21.1% |
| Q1 2014 | $13,704,000 | -35.8% | 515,406 | -51.3% | 0.08% | +26.7% |
| Q4 2013 | $21,358,000 | +742.9% | 1,058,398 | +639.1% | 0.06% | +361.5% |
| Q3 2013 | $2,534,000 | – | 143,193 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |